ArticlePathogenic Role of Interlukin-23(IL-23) in Rheumatoid Arthritis Patients; its Relation to Disease Activity
ArticlePathogenic Role of Interlukin-23(IL-23) in Rheumatoid Arthritis Patients; its Relation to Disease Activity
ArticleRole of interleukin-17 and interleukin 23R gene polymorphism and serum interleukin 17A in rheumatoid arthritis
ArticleRole of interleukin-17 and interleukin 23R gene polymorphism and serum interleukin 17A in rheumatoid arthritis
ArticleSerum Interleukin-17 Level in Patients with Rheumatoid Arthritis and its Relation to Disease Activity
ArticleSerum Interleukin-17 Level in Patients with Rheumatoid Arthritis and its Relation to Disease Activity
ArticleInterleukin-22 and Tumor Necrosis Factor Receptor Associated Factor 1 (TRAF1) in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus: Correlation with Disease Activity
ArticleInterleukin-22 and Tumor Necrosis Factor Receptor Associated Factor 1 (TRAF1) in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus: Correlation with Disease Activity
ArticleThe Use of Interleukin-22 as a Novel Marker of Disease Activity in Female Patients with Rheumatoid Arthritis
ArticleThe Use of Interleukin-22 as a Novel Marker of Disease Activity in Female Patients with Rheumatoid Arthritis
ArticleInterleukin-10, Interleukin- 16 and Interferon-γ in serum of patients with rheumatoid arthritis and correlation with disease activity
ArticleInterleukin-10, Interleukin- 16 and Interferon-γ in serum of patients with rheumatoid arthritis and correlation with disease activity